158 related articles for article (PubMed ID: 34915668)
1. Central high mobility group box-1 induces mechanical hypersensitivity with spinal microglial activation in a mouse model of hemi-Parkinson's disease.
Sato F; Nakamura Y; Ma S; Kochi T; Hisaoka-Nakashima K; Wang D; Liu K; Wake H; Nishibori M; Morioka N
Biomed Pharmacother; 2022 Jan; 145():112479. PubMed ID: 34915668
[TBL] [Abstract][Full Text] [Related]
2. Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease.
Sasaki T; Liu K; Agari T; Yasuhara T; Morimoto J; Okazaki M; Takeuchi H; Toyoshima A; Sasada S; Shinko A; Kondo A; Kameda M; Miyazaki I; Asanuma M; Borlongan CV; Nishibori M; Date I
Exp Neurol; 2016 Jan; 275 Pt 1():220-31. PubMed ID: 26555088
[TBL] [Abstract][Full Text] [Related]
3. Perineural high-mobility group box 1 induces mechanical hypersensitivity through activation of spinal microglia: Involvement of glutamate-NMDA receptor dependent mechanism in spinal dorsal horn.
Nakamura Y; Fukuta A; Miyashita K; Zhang FF; Wang D; Liu K; Wake H; Hisaoka-Nakashima K; Nishibori M; Morioka N
Biochem Pharmacol; 2021 Apr; 186():114496. PubMed ID: 33667472
[TBL] [Abstract][Full Text] [Related]
4. In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin.
Santoro M; Maetzler W; Stathakos P; Martin HL; Hobert MA; Rattay TW; Gasser T; Forrester JV; Berg D; Tracey KJ; Riedel G; Teismann P
Neurobiol Dis; 2016 Jul; 91():59-68. PubMed ID: 26921471
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
6. Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis.
Agalave NM; Larsson M; Abdelmoaty S; Su J; Baharpoor A; Lundbäck P; Palmblad K; Andersson U; Harris H; Svensson CI
Pain; 2014 Sep; 155(9):1802-1813. PubMed ID: 24954167
[TBL] [Abstract][Full Text] [Related]
7. Spinal high-mobility group box-1 induces long-lasting mechanical hypersensitivity through the toll-like receptor 4 and upregulation of interleukin-1β in activated astrocytes.
Morioka N; Miyauchi K; Miyashita K; Kochi T; Zhang FF; Nakamura Y; Liu K; Wake H; Hisaoka-Nakashima K; Nishibori M; Nakata Y
J Neurochem; 2019 Sep; 150(6):738-758. PubMed ID: 31273787
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a role for spinal HMGB1 in ischemic stress-induced mechanical allodynia in mice.
Matsuura W; Harada S; Liu K; Nishibori M; Tokuyama S
Brain Res; 2018 May; 1687():1-10. PubMed ID: 29476751
[TBL] [Abstract][Full Text] [Related]
9. Spinal alarmin HMGB1 and the activation of TLR4 lead to chronic stress-induced nociceptive hypersensitivity in rodents.
Rodríguez-Palma EJ; Velazquez-Lagunas I; Salinas-Abarca AB; Vidal-Cantú GC; Escoto-Rosales MJ; Castañeda-Corral G; Fernández-Guasti A; Granados-Soto V
Eur J Pharmacol; 2023 Aug; 952():175804. PubMed ID: 37244377
[TBL] [Abstract][Full Text] [Related]
10. Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR I and TLR4 pathways.
Zhang J; Niu N; Wang M; McNutt MA; Zhang D; Zhang B; Lu S; Liu Y; Liu Z
Int J Biochem Cell Biol; 2013 Aug; 45(8):1911-20. PubMed ID: 23791745
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory process in Parkinson disease: neuroprotection by neuropeptide Y.
Pain S; Vergote J; Gulhan Z; Bodard S; Chalon S; Gaillard A
Fundam Clin Pharmacol; 2019 Oct; 33(5):544-548. PubMed ID: 30866091
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
[TBL] [Abstract][Full Text] [Related]
13. A time-course study of microglial activation and dopaminergic neuron loss in the substantia nigra of mice with paraquat-induced Parkinson's disease.
Yang HM; Wang YL; Liu CY; Zhou YT; Zhang XF
Food Chem Toxicol; 2022 Jun; 164():113018. PubMed ID: 35430334
[TBL] [Abstract][Full Text] [Related]
14. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
15. Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease.
Pereira CPM; Francis-Oliveira J; Singulani MP; Ferreira AFF; Britto LRG
J Neuroimmunol; 2023 Feb; 375():578019. PubMed ID: 36681049
[TBL] [Abstract][Full Text] [Related]
16. HMGB1 A box protects neurons by potently inhibiting both microglia and T cell-mediated inflammation in a mouse Parkinson's disease model.
Tian Y; Cao Y; Chen R; Jing Y; Xia L; Zhang S; Xu H; Su Z
Clin Sci (Lond); 2020 Aug; 134(15):2075-2090. PubMed ID: 32706028
[TBL] [Abstract][Full Text] [Related]
17. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
18. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration.
Gao HM; Zhou H; Zhang F; Wilson BC; Kam W; Hong JS
J Neurosci; 2011 Jan; 31(3):1081-92. PubMed ID: 21248133
[TBL] [Abstract][Full Text] [Related]
20. Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration.
Hernandes MS; Santos GD; Café-Mendes CC; Lima LS; Scavone C; Munhoz CD; Britto LR
PLoS One; 2013; 8(9):e75532. PubMed ID: 24086556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
